A large international study has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients. Transplant recipients were shown to require lower levels of immunosuppression in order to prevent organ rejection. This reduces the risk of side effects such as viral infections.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/06/200610111933.htm
No comments:
Post a Comment